The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.
Study Type
OBSERVATIONAL
Enrollment
4,732
Clinical outcomes
Disease-free Survival
The primary end points were the cumulative incidence of pregnancy and disease-free survival.
Time frame: 10 years
Cumulative Incidence of Pregnancy After Breast Cancer
The primary end points were the cumulative incidence of pregnancy and disease-free survival.
Time frame: 10 years
Breast Cancer-Specific Survival
A breast cancer-specific survival event was defined as death due to breast cancer, and patients who died for reasons other than breast cancer were censored at the date of death.
Time frame: 10 years
Overall Survival
An overall survival event was defined as death due to any cause.
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Yale University
New Haven, Connecticut, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Michigan State University
Lansing, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
University of North Carolina - Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio, United States
Lifespan Cancer Institute
Providence, Rhode Island, United States
Hospital Aleman
Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina
Instituto Alexander Fleming
Buenos Aires, Argentina
...and 71 more locations